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Adiponectin and interleukin 10 (IL-10) are adipokines that are predominantly secreted by differentiated
adipocytes and are involved in energy homeostasis, insulin sensitivity, and the anti-inﬂammatory
response. These two adipokines are reduced in obese subjects, which favors increased activation of
nuclear factor kappa B (NF-jB) and leads to elevation of pro-inﬂammatory adipokines. However, the
effects of adiponectin and IL-10 on NF-jB DNA binding activity (NF-jBp50 and NF-jBp65) and proteins
involved with the toll-like receptor (TLR-2 and TLR-4) pathway, such as MYD88 and TRAF6 expression, in
lipopolysaccharide-treated 3T3-L1 adipocytes are unknown. Stimulation of lipopolysaccharide-treated
3T3-L1 adipocytes for 24 h elevated IL-6 levels; activated the NF-jB pathway cascade; increased protein
expression of IL-6R, TLR-4, MYD88, and TRAF6; and increased the nuclear activity of NF-jB (p50 and p65)
DNA binding. Adiponectin and IL-10 inhibited the elevation of IL-6 levels and activated NF-jB (p50 and
p65) DNA binding. Taken together, the present results provide evidence that adiponectin and IL-10 have
an important role in the anti-inﬂammatory response in adipocytes. In addition, inhibition of NF-jB sig-
naling pathways may be an excellent strategy for the treatment of inﬂammation in obese individuals.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
White adipose tissue plays a role in energy storage and insula-
tion from environmental temperature and trauma. Recent ad-
vances in adipose biology have provided convincing evidence
that adipocytes also secrete multiple proteins (i.e., adipokines) that
inﬂuence metabolism in peripheral tissues [1,2]. Obesity has been
shown to cause an increase in plasma concentrations of a number
of pro-inﬂammatory (e.g., IL-6, TNF-a) markers that are expressed
and released by adipocytes [3]. In addition, the pro-inﬂammatory
status in obesity promotes a decrease in anti-inﬂammatory adipo-
kines, such as adiponectin and IL-10 plasma concentrations [4,5].
Previous studies [6,7] have shown that nuclear factor jB (NF-
jB) transcription factor is a key mediator of inﬂammation in adi-
pose tissue. New data have shown a close relationship between
toll-like receptor 4 (TLR-4) and activation of the NF-jB pathway,
which leads to an elevation of pro-inﬂammatory adipokine gene
and protein expression in adipose tissue [8,9].de Fisiologia, Universidade
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ira), claudia.oller@unifesp.br
ier OA license.Cani et al. [3] showed that increased endotoxin levels in obesity
may be a key factor for the initiation of inﬂammation in adipose
tissue, and the prototypical endotoxin, lipopolysaccharide (LPS),
acts on TLR-4. Toll-like receptors are transmembrane proteins that
play an important role in recognizing microbial pathogens and
mediating whole body inﬂammation [10]. They are highly
expressed in cells of the innate immune system [11]. In addition,
TLR-2 and TLR-4 are also found in various other cell types, includ-
ing adipocytes, hepatocytes, and myocytes [12,13].
Studies have shown that adiponectin and interleukin 10 (IL-10),
two adipocyte-derived cytokines, act as potent inhibitors of
inﬂammatory responses [6,7,14,15].
Zoico et al. [7] demonstrated that globular adiponectin and full-
length adiponectin decreased NF-jB activity in 3T3-L1 adipocytes
by 50% and 40%, respectively, compared with the NF-jB activation
induced by LPS alone. This result demonstrated the important anti-
inﬂammatory role of adiponectin to combat obesity-mediated
inﬂammation.
Interestingly, Turner et al. [16] explored the anti-inﬂammatory
effects of IL-10 in primary human cultures of differentiated adipo-
cytes and found that IL-10 was ineffective against TLR-4-induced
cytokine secretion. Human adipocytes, however, do not express
the IL-10 receptor, which has been shown to respond to IL-10 in
the murine 3T3-L1 adipocyte model.
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activity (NF-jBp50 and NF-jBp65) and the expression of proteins
involved in the signaling of the toll-like receptor (TLR-2 and TLR-4)
pathway, such as MYD88 and TRAF6, in lipopolysaccharide-treated
3T3-L1 adipocytes are not clear.
In the present study, we analyzed the effects of adiponectin, IL-
10, and the combination of adiponectin and IL-10 on TLR-2, TLR-4
and the NF-jB pathway in 3T3-L1 adipocytes in the presence of
LPS.2. Materials and methods
2.1. Cell culture
3T3-L1 cells were obtained from American Type Culture Collec-
tion and cultured at 37 C in 5% CO2/95% humidiﬁed air. The cells
were maintained in Dulbecco´s Eagle modiﬁed medium (DMEM)
with 25 mM glucose, 1.0 mM pyruvate, 4.02 mM L-alanine-gluta-
mine, and 10% fetal bovine serum (Gibco, New York, USA). Cell dif-
ferentiation began 24 h after conﬂuence and took 4 days in a
medium containing 0.25 lM dexamethasone, 0.5 mM 3-isobutyl-
1-methylxanthine, and 5 lg/mL insulin (Sigma). After differentia-
tion, the cells were cultured for 8 days in growth medium contain-
ing 5 lg/mL insulin.
2.2. Treatment
On the tenth day after differentiation, the cells were pretreated
for a 24-h period with a medium containing 0.5% serum fetal bo-
vine. The cells were harvested 24 h later. Cells were treated with
adiponectin (50 ng/mL), IL-10 (5 ng/mL) or a combination of adipo-
nectin (50 ng/mL) and IL-10 (5 ng/mL) for 24 h in the presence of
LPS (100 ng/mL), and harvested 24 h later. In the control plates
(C), the medium was changed, but no treatment was added. The
cultured medium and adipocytes were collected in tubes and
stored at 80 C.
Preliminary experiments were performed to determine the con-
centrations of adiponectin and IL-10 (data not shown). In addition,
we previously ran a time-course experiment (3, 6, 12, and 24 h of
treatment).
2.3. Determination of the IL-6 level in the adipocyte culture medium
Quantitative assessment of IL-6 levels in the culture medium
was performed using an enzyme linked immunosorbent assay (ELI-
SA) (DuoSet ELISA, R&D Systems, Minneapolis, MN). The IL-6
(DY506) assay sensitivity was found to be 5.0 pg/mL, and the range
was 31.2–2000 pg/mL. The intra- and inter-assay variability of the
IL-6 kit was 2.7–5.2%. All samples were run in triplicate, and the
mean value was used for analysis. The protein concentration of
3T3-L1 adipocytes was determined by the Bradford assay
(Bio-Rad, Hercules, CA, USA) using bovine serum albumin (BSA)
as a standard. The results are expressed in pg/lg protein.
2.4. Protein analysis by Western blotting
3T3-L1adipocyte cellswerehomogenized in1.0 mLof solubiliza-
tion buffer at 4 C [1% Triton X-100, 100 mM Tris–HCl (pH 7.4),
100 mM sodium pyrophosphate, 100 mM sodium ﬂuoride, 10 mM
EDTA, 10 mM sodium orthovanadate, 2 mM phenylmethylsulfonyl
ﬂuoride (PMSF), and 0.1 mg aprotinin/mL]. Insoluble material was
removed by centrifugation for 30 min at 9000g in a 70 Ti rotor
(Beckman, Fullerton, CA, USA) at 4 C. The protein concentration of
the supernatants was determined with a BCA assay (Bio-Rad,
Hercules, CA, USA). Proteins were denatured by boiling (5 min) inLaemmli sample buffer [17] containing 100 mM DTT and subjected
to 10% SDS–PAGE in a Bio-Rad miniature slab gel apparatus.
Electrotransfer of proteins from the gel to nitrocellulose mem-
branes was performed for 1.30 h/4 gels at 15 V (constant) in a
Bio-Rad semi-dry transfer apparatus. Nonspeciﬁc protein binding
to the nitrocellulose was reduced by preincubation for 2 h at
22 C in blocking buffer (5% nonfat dry milk, 10 mM Tris,
150 mM NaCl, and 0.02% Tween 20). The nitrocellulose membranes
were incubated overnight at 4 C with antibodies against IL-6R,
TLR-2, TLR-4, MYD88, TRAF6, and alpha-tubulin (Santa Cruz Bio-
technology, CA, USA), which were all diluted 1:1000 in blocking
buffer with 1% BSA. After incubation, the membranes were washed
for 30 min in blocking buffer without BSA. The blots were subse-
quently incubated with peroxidase-conjugated secondary antibody
for 1 h at 22 C. For the evaluation of protein loading, membranes
were stripped and reblotted with anti-alpha-tubulin antibody as
appropriate. Speciﬁc bands were detected by chemiluminescence,
and visualization/capture was performed by exposure of the mem-
branes to RX ﬁlms. Band intensities were quantiﬁed by optical den-
sitometry of developed autoradiographs (Scion Image software,
Scion Corporation, Frederick, MD, USA).
2.5. Nuclear extraction
3T3-L1 adipocytes were rapidly removed and homogenized in
accordance with the manufacturer’s instructions for the Panomics
Nuclear Extraction Kit (AY2002). The nuclear fraction was stored at
80 C.
2.6. NF-jBp50 and NF-jBp65 DNA binding assay
Nuclear-localized NF-jB was quantiﬁed using a Transcription
Factor ELISA Kit to detect the DNA binding of the p50 and p65 sub-
units of NF-jB (Panomics, Fremont, CA; EK 1110 and 1120, respec-
tively). All reagents required for preparing nuclear extracts and
performing ELISA assays were included, and all reagents were used
as described by the manufacturer.
2.7. Statistical analysis
The results are expressed as the mean ± S.E.M. We used Stu-
dent’s t test to compare the treatment effects (control vs. LPS;
LPS vs. LPS + adiponectin; LPS vs. LPS + IL-10; and LPS vs.
LPS + adiponectin and IL-10). Values of p < 0.05 were considered
to be statistically signiﬁcant.3. Results
3.1. Time course
Fig. 1A–D shows that the IL-6 levels in the culture medium after
3, 6, 12, and 24 h were higher in the LPS, LPS + adiponectin,
LPS + IL-10, and LPS + adiponectin and IL-10 groups compared with
the control group (p < 0.05).
Interestingly, the IL-6 level was lower in LPS group after 3 h
compared with the other treatments (p < 0.05).
After 6 h, IL-10 and LPS reduced the IL-6 level compared with
LPS alone. Conversely, LPS + adiponectin increased the IL-6 level
compared with LPS alone, LPS + IL-10 and LPS + IL-10 and adipo-
nectin (p < 0.05).
In addition, adipokines incubated with LPS for 24 h induced an
approximately 25% decrease in the IL-6 level in the culture
medium.
We observed similar results for NF-jBp50 nuclear activity in
adipocytes after 3 and 6 h of treatment among groups (Fig. 2A
Fig. 1. Time course of IL-6 release in the culture medium of 3T3-L1 adipocytes treated with LPS, LPS + IL-10, LPS + adiponectin. n = 6 for all groups. ⁄Values are means ± SE.
⁄p < 0.05 in relation to control, #p < 0.05 in relation to LPS.
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in NF-jBp50 nuclear activity in adipocytes compared with the
other groups (p < 0.01) (Fig. 2C and D).
The NF-jBp65 nuclear activity in adipocytes was increased by
LPS treatment at all examined time points compared with control
and adipokine-treated groups. The addition of adiponectin, IL-10 or
adiponectin + IL-10 decreased the effect of LPS (Fig. 3A–D) on NF-
jBp65 nuclear activity in adipocytes. After 6, 12 and 24 h of adipo-
kine treatment, this parameter was similar to the control group
(Fig. 3B–D).
After determining the best time response for our treatments
with adipokines, we chose to assess the 24-h time point, and we
divided our study into three distinct experiments. We assessed
the effects of adiponectin, IL-10, and adiponectin combined with
IL-10 on TLR-2, TLR-4 and on the NF-jB pathway in adipocytes
in the presence the LPS.
Previous studies have shown that LPS induces NF-jB activation
and IL-6 production in adipocytes [1,6,7,18]. In addition, we ob-
served that LPS increased TLR-4, MYD88, and TRAF6 expression.
These data demonstrate a classic LPS-mediated pro-inﬂammatory
response in adipocytes. These results are shown in Figs. 4A–D
and 5A–D.
Figs. 6A–D and 7A–D show the effects of adiponectin on the
LPS-induced inﬂammatory response in adipocytes. Compared with
LPS alone, adiponectin reduced IL-6 levels and both NF-jBp50 and
NF-jBp65 nuclear activity in adipocytes (p < 0.05). In addition,
adiponectin increased TLR-2, MYD88, and TRAF6 protein expres-
sion compared with LPS alone (p < 0.05).
Figs. 8A–D and 9A–D show the effects of IL-10 on the LPS-in-
duced inﬂammatory response in adipocytes. Compared with LPS
alone, IL-10 reduced the IL-6 level and NF-jBp50 and NF-jBp65
nuclear activity in adipocytes (p < 0.05). We did not observe any ef-
fects of IL-10 on TLR-2, MYD88, or TRAF6 protein expression.Figs. 10A–D and 11A–D show the effects of adiponectin com-
bined with IL-10 on the LPS-induced inﬂammatory response in
adipocytes. Compared with LPS alone, the combination of adipo-
nectin and IL-10 reduced the IL-6 level, MYD88 protein expres-
sion and NF-jBp50 and NF-jBp65 nuclear activity in adipocytes
(p < 0.01).4. Discussion
The present study shows that the treatment with anti-inﬂam-
matory adipokines was effective in reducing the activation of
inﬂammatory pathways, especially the NF-jB pathway. In addi-
tion, anti-inﬂammatory adipokines decreased IL-6 levels.
In agreement with previous studies, LPS caused an increase in
IL-6, IL-6R, TLR-4, MYD88, and TRAF6 protein expression and in
the nuclear activity of NF-jB (p50 and p65) DNA binding [6,7,19].
One of the questions addressed in the present study was how
adiponectin would affect the inﬂammatory response in the pres-
ence of LPS. We observed that the addition of adiponectin reduced
NF-jB (both p50 and p65) activation.
Ajuwon and Spurlock [6] showed that adiponectin may be a lo-
cal regulator of inﬂammation in the adipocyte and adipose tissue
via its regulation of the NF-jB and PPARc2 transcription factors.
They used primary adipocytes from pig subcutaneous adipose tis-
sue with or without treatment with LPS and adiponectin. Although
LPS induced an increase in NF-jB activation, adiponectin sup-
pressed both NF-jB activation and the induction of IL-6 expression
by LPS. Similar results were obtained in 3T3-L1 adipocytes. In addi-
tion, adiponectin antagonized the LPS-induced increase in TNF-a
mRNA expression and lead towards a reduction of its accumulation
in the culture media in 3T3-L1 adipocytes. Adiponectin also in-
duced an upregulation of PPARc2 mRNA.
Fig. 2. Time course of DNA-binding activity of NF-kBp50 in 3T3-L1 adipocytes treated with LPS, LPS + IL-10, LPS + adiponectin. n = 6 for all groups. ⁄Values are means ± SE.
⁄p < 0.05 in relation to control, #p < 0.05 in relation to LPS.
Fig. 3. Time course of DNA-binding activity of NF-kBp65 in 3T3-L1 adipocytes treated with LPS, LPS + IL-10, LPS + adiponectin. n = 6 for all groups. Values are means ± SE.
⁄p < 0.05 in relation to control, #p < 0.05 in relation to LPS.
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Fig. 4. Effect of LPS for 24 h on the IL-6 level in culture medium and on the 3T3-L1 protein expression of IL-6R, TLR-2, and TLR-4. n = 6 for all groups. Values are means ± SE.
⁄p < 0.05 and ⁄⁄⁄p < 0001 in relation to control.
Fig. 5. Effect of LPS for 24 h on the 3T3-L1 protein expression of MYD88, TRAF6, NF-kBp50, NF-kBp65. n = 6 for all groups. Values are means ± SE. ⁄p < 0.05 and ⁄⁄⁄p < 0001 in
relation to control.
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showed that adiponectin (two isoforms of adiponectin: globular
and full length) signiﬁcantly suppressed LPS-induced expression
of IL-6 mRNA in adipocytes and reduced the concentration of IL-
6 in culture media. Adiponectin pretreatment signiﬁcantly reduced
the increase in monocyte chemotactic protein 1 (MCP-1) mRNA in
adipocytes exposed to LPS. In culture media, the increase in MCP-1
detected after LPS stimulation was signiﬁcantly attenuated after
pretreatment with adiponectin. In 3T3-L1, adiponectin reduced
NF-jB activity by 50% compared with the NF-jB activation in-
duced by LPS alone. Moreover, adiponectin signiﬁcantly attenuated
IkappaB-alpha and IKK gene expression.Using macrophages, Park et al. [20] demonstrated the mecha-
nism by which adiponectin suppresses the inﬂammatory pathway.
They showed that adiponectin initially increases TNF-a production
by macrophages via ERK1/2, Egr-1, and NF-jB-dependent mecha-
nisms, which leads to increased expression of IL-10 and an even-
tual dampening of LPS-mediated cytokine production.
Traditionally, LPS is speciﬁc for TLR-4, and TLR-2 is a receptor
for bacterial lipoproteins [21]. Lin et al. [12] reported that acute
LPS induced TLR-2 expression, which was consistent with the
notion that TLR-4, but not TLR-2, is constitutively present on the
cell surface of 3T3-L1 adipocytes. In addition, TLR-4 activation
results in induction of TLR-2, and this newly synthesized TLR-2
Fig. 6. Effect of adiponectin treatment for 24 h on IL-6 level in the culture medium and on protein expression of IL-6R, TLR-2, and TLR-4 in 3T3-L1 adipocyte treated with LPS.
n = 6 for all groups. Values are means ± SE. ⁄p < 0.05 in relation to LPS.
Fig. 7. Effect of adiponectin treatment for 24 h on protein expression of MYD88, TRAF6, NF-kBp50, NF-kBp65 in 3T3-L1 adipocyte treated with LPS. n = 6 for all groups. Values
are means ± SE. ⁄p < 0.05 in relation to LPS.
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signaling.
Unexpectedly, adiponectin addition to the culture medium of
3T3-L1 adipocytes increased protein expression of TLR-2, MYD88,
and TRAF6 compared with the levels induced by LPS alone, which
demonstrated that the reduced NF-jB (both p50 and p65) activa-
tion caused by adiponectin was not related to an effect on the
TLR-4 pathway; however, this could be associated with a decrease
in IL-6.
One possible interpretation is that TLR-4 recruits TLR-2
into a complex. Alternatively, TLR-4 activation could result in
the activation of intracellular effectors that could associate
with TLR-2. This interaction may also be involved in other
intracellular signaling pathways because both IL-6 and NF-jB
are reduced. In addition, TLR-2, MYD88, and TRAF6 wereincreased, and they could participate in other noninﬂammatory
pathways.
The present study also investigated the effects of IL-10 on the
LPS-induced inﬂammatory response. We observed that IL-10 re-
duced the IL-6 level and NF-jB (both p50 and p65) DNA binding.
In contrast to adiponectin, fewer studies have been conducted to
investigate the effects of IL-10 in adipocytes and the inﬂammatory
response.
Interleukin 10 inhibits the production of several cytokines, such
as TNF-a, IL-1b, and IL-6, in a variety of cell types. Several studies
have shown that the production of IL-10 is increased in inﬂamma-
tory processes and predominantly plays an immune modulating
role in these conditions [15,19]. In obesity, adiponectin and IL-10
serum levels are decreased, which leads to a pro-inﬂammatory sta-
tus [4].
Fig. 8. Effect of IL-10 treatment for 24 h on IL-6 level in the culture medium and on protein expression of IL-6R, TLR-2, and TLR-4 in 3T3-L1 adipocyte treated with LPS. n = 6
for all groups. Values are means ± SE. ⁄p < 0.05 in relation to LPS.
Fig. 9. Effect of IL-10 treatment for 24 h on protein expression of MYD88, TRAF6, NF-kBp50, NF-kBp65 in 3T3-L1 adipocyte treated with LPS. n = 6 for all groups. Values are
means ± SE. ⁄p < 0.05 in relation to LPS.
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3T3-L1 adipocytes incubated with palmitic acid for 24 h exhibited
a 70% increase in TNF-a production and up to a 75% decrease in IL-
10 production. Furthermore, NF-jB DNA binding activity increased
fourfold in response to palmitic acid.
Turner et al. [16] examined the anti-inﬂammatory effects of
IL-10 in primary human adipocytes and showed that IL-10 did
not inhibit TLR-4-induced cytokine secretion. Interestingly, a
different result was observed in the 3T3-L1 adipocyte model. The
authors suggested that the receptor for IL-10 was absent in humansubcutaneous adipocytes. However, recently it has been shown in
human primary adipocytes the gene expression of IL-10Ra and
IL-10Rb [23]. Taken together, the studies suggest that IL-10 may
act on human adipocytes, depending on the conditions and the
primary adipose pad from which these cells are derived.
Cintra et al. [24] administered an endogenous IL-10 inhibitor for
5 days to male Swiss mice and demonstrated an increase in hepatic
expression of inﬂammatory markers, such as TNF-a, IL-6, IL-1b,
and F4/80. This increase in inﬂammatory markers was accompa-
nied by a signiﬁcant negative modulation of insulin signal
Fig. 10. Effect of IL-10 + adiponectin treatment for 24 h on IL-6 level in the culture medium and on protein expression of IL-6R, TLR-2, and TLR-4 in 3T3-L1 adipocyte treated
with LPS. n = 6 for all groups. Values are means ± SE. ⁄p < 0.05 in relation to LPS.
Fig. 11. Effect of IL-10 + adiponectin treatment for 24 h on protein expression of MYD88, TRAF6, NF-kBp50, NF-kBp65 in 3T3-L1 adipocyte treated with LPS. n = 6 for all
groups. Values are means ± SE. ⁄p < 0.05 in relation to LPS.
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Akt/FOXO1 pathway and through an increase in hepatic signaling
proteins involved in gluconeogenesis and lipid synthesis.
Strategies such as energy restriction and exercise training have
been adopted to promote increases in the IL-10 serum level and
adipose tissue production, which would reduce the inﬂammatory
status [4,15,19,25]. The pathway that mediates this IL-10 effect
in 3T3-L1 adipocytes, however, is unknown. We demonstrated that
the addition of IL-10 to the culture medium decreased NF-jB DNA
binding activity in 3T3-L1 adipocytes independent of the TLR
pathway.We also examined the effects of adiponectin combined with IL-
10 on the LPS-induced inﬂammatory response. Interestingly, we
observed that the combination of adiponectin and IL-10 reduced
IL-6 levels, the protein expression of MYD88, and NF-jB (both
p50 and p65) DNA binding.
Almost all TLRs have a common signaling pathway in which
MYD88 adaptor molecules form a molecular complex with TLR-
initiated signaling events. MYD88 also interacts with downstream
IL-1R-associated kinase (IRAKs) [26], and TRAF6 regulates distinct
processes of innate and adaptive immunity mediated by IkB
kinases (IKK) that regulate NF-jB [27,28]. The combination of
106 F.S. Lira et al. / Cytokine 57 (2012) 98–106adiponectin and IL-10 altered the MYD88-dependent pathway,
which led to a decrease in NF-jB (both p50 and p65) DNA binding.
Tsan and Gao [21] reported that TLR1/2, TLR2/6, and TLR4 (but not
other TLRs) induced NF-jB activation through a MYD88-depen-
dent pathway.
More studies are needed to fully elucidate the comprehensive
pathway involved with anti-inﬂammatory responses in adipocytes
and conﬁrm their importance in vivo.
In summary, we demonstrated that adiponectin, IL-10 and the
combination of adiponectin and IL-10 all reduced NF-jB (both
p50 and p65) DNA binding in 3T3-L1 adipocytes exposed to LPS,
which may have resulted from a reduction in IL-6 production
rather than from an inhibition of the TLR-4 pathway. The present
results suggest that anti-inﬂammatory adipokines may be utilized
as a strategy to reduce the pro-inﬂammatory state in obese people.
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